Stock transaction disclosure

VRTX

Vertex Pharmaceuticals Incorporated - Common Stock

AA

Armstrong, Alan

R-OKsenate

Reported action

Purchase

Disclosed amount range

$1,001 - $15,000

Transaction date

Mar 27, 2026

Filing date

Jul 21, 2026

Reported owner

self

Filing timeliness

71 days late

Committee oversight: Member, Senate Committee on Health, Education, Labor, and Pensions (Drug pricing, health insurance, biotech)

Amounts are disclosed ranges, not exact transaction values. Senate coverage is complete; House coverage is partial.

All disclosures for VRTX →